MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 194 filers reported holding MYRIAD GENETICS INC in Q4 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $382,725 | +6.9% | 15,647 | -6.8% | 0.08% | 0.0% |
Q1 2024 | $358,112 | +6.3% | 16,797 | -4.6% | 0.08% | -5.7% |
Q4 2023 | $336,884 | +6.7% | 17,601 | -10.6% | 0.09% | -6.4% |
Q3 2023 | $315,779 | -58.4% | 19,687 | -50.0% | 0.09% | -24.8% |
Q2 2023 | $759,559 | +70.0% | 39,335 | +104.5% | 0.12% | -10.1% |
Q1 2023 | $446,852 | +97.3% | 19,236 | +23.3% | 0.14% | +40.4% |
Q4 2022 | $226,429 | – | 15,605 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tieton Capital Management, LLC | 122,428 | $3,618,000 | 3.32% |
Sensato Investors LLC | 553,505 | $16,356,000 | 2.54% |
Camber Capital Management LP | 1,500,000 | $44,325,000 | 2.18% |
S&T BANK/PA | 387,084 | $11,439,000 | 2.04% |
Taylor Frigon Capital Management LLC | 46,989 | $1,389,000 | 1.08% |
AIMZ Investment Advisors, LLC | 43,785 | $1,294,000 | 0.94% |
Matarin Capital Management, LLC | 398,828 | $11,785,367,000 | 0.88% |
Summit Street Capital Management, LLC | 30,097 | $889,000 | 0.88% |
DISCIPLINED GROWTH INVESTORS INC /MN | 1,321,171 | $39,041,000 | 0.77% |
Millrace Asset Group, Inc. | 45,544 | $1,346,000 | 0.65% |